Clinical trials recruiting for EGFR Mutant Advanced Non-small Cell Lung Cancer
3
Recruiting trials
1
US states with sites
4
Countries
33%
Accept healthy volunteers
Phase breakdown
Phase 1 2Phase 2 1Not applicable 1
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| JIN-A02 | 1 |
| [14C]Zorifertinib Oral Formulation | 1 |
| zorifertinib | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 1 |
Top cities
Self-screener
Recruiting trials
- A Phase 1/2 Study to Evaluate the Safety, Tolerability and PK of JIN-A02 in Patients With EGFR Mutant Advanced NSCLC
- A Prospective Cohort Study of Zorifertinib as a First-line Treatment in Patients With Epidermal Growth Factor Receptor-mutant Advanced Non-small Cell Lung Cancer With Central Nervous System (CNS) Metastases
- Material Balance of [14C]Zorifertinib in Healthy Adult Male Participants in China
Related conditions
Trials recruiting for EGFR Mutant Advanced Non-small Cell Lung Cancer often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for EGFR Mutant Advanced Non-small Cell Lung Cancer trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.